2013-12-25

Fosun Pharma won the Best Investor Relations Award

On Dec. 18th, 2013, Fosun Pharma won the Best Investor Relations Award of the Selection of 2013 China's Most Valuable Listed Companies initiated by ND Media.

With the criteria of fairness, justice and public trust, the selection made in-depth analysis of listed companies from the media perspective to finally select those elite companies, quality products and leading individuals with supreme expertise and leading innovative service. According to the criteria, all the candidates must have timely, complete and accurate information disclosure; be not subject to regulatory punishment in the latest three years; have sufficient exchange between the managers and investors; as well as optimized information disclosure system, compliance and responsibility.

The corporate governance is a leading indicator for dividends and finance, Ma Lianfu, the event judge; Head of Institute of Modern Management, Business School of Nankai University; and Vice Director of Chinese Academy of Corporate Governance stated that in the past, the investors were most looking at corporate financial indicators; and that after the introduction of the differentiated dividend policies, the investors will change the current price speculation into value investment, who are more concerned about the long-term benefits and the future of the company, therefore they must watch the governance of listed companies. According to him, to truly protect the interests of investors, the systems of registration, delisting and litigation compensation for investors should also be established to practically drive the governance of listed companies.